Integration, Pharmaceuticals, Public Health services and Regulations

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Integration

Pharmaceuticals

Public Health services

Regulations

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill Of Health

SEPTEMBER 28, 2023

Pressure from Senator Bernie Sanders, Chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee seems to have catalyzed the administration to make this move. pharmaceutical market. Federal support by BARDA and the CDC have de-risked the development of medical products for the pharmaceutical industry.

Pharmaceuticals

Pharmaceuticals Biotechnology Integration Public Health services

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Sheppard Health Law

FEBRUARY 22, 2023

Each manufacturer must pay the rebate within thirty (30) days of receiving the invoice and failure to pay will result in civil monetary penalties (“CMPs”), which CMS will establish through regulations, including a penalty equal to at least one hundred twenty-five percent (125%) of the rebate amount. 9, 2023). [2]

Medicare

Medicare Medicaid Pharmaceuticals Public Health services

Health Care Quality Digest

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Stay Connected